Review of von Willebrand Disease and Perioperative Management in Dentistry
von Willebrand disease (vWD) is the most common inherited coagulation disorder. In addition, vWD can also be acquired later in life in patients with no previous history of pathologic bleeding. vWD is the result of either a quantitative deficit or a qualitative defect in von Willebrand factor (vWF). Each patient’s disease is classified based on the type of defect in vWF. Dental and surgical management of patients with vWD is based on the severity of their disease, and several systemic and local treatments are available to allow for the hemorrhage control. This chapter will review important aspects of vWF, classification of vWD, and treatment of the dental patient with vWD.
Keywordsvon Willebrand disease (vWD) von Willebrand factor (vWF) Endothelial cells Subendothelium Platelet membrane receptor Glycoprotein Ib/IX/V Mucocutaneous bleeding Desmopressin Aminocaproic acid Tranexamic acid
- 5.Lillicrap D. The basic science, diagnosis, and clinical management of von Willebrand disease. Treatment of Hemophilia. Monograph No. 35. 2008:18.Google Scholar
- 9.Wagner DD, Ginsburg D. Structure, biology, and genetics of von Willebrand factor. In: Hoffman R, et al., editors. Hematology: basic principles and practice. 2nd ed. New York: Churchill Livingstone; 1995. p. 1717–25.Google Scholar
- 16.Hall JE. Guyton and hall textbook of medical physiology. 12th ed. Philadelphia: W.B. Saunders Company; 2011.Google Scholar
- 27.O’Reilly RA. Anticoagulant, antithrombotic, and thrombolytic drugs. In: Gilman AG, Goodman LS, Rall TW, Murad F, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 7th ed. New York: Macmillan Publishing Company; 1985. p. 1338–62.Google Scholar
- 28.Hamilton R, editor. Tarascon pocket pharmacopoeia. Burlington, MA: Jones & Bartlett Publishing; 2015.Google Scholar